Skip to main content
. 2018 Nov 16;21(2):131–136. doi: 10.4103/aja.aja_85_18

Figure 1.

Figure 1

Kaplan–Meier analysis of (a) PSA progression-free survival, (b) clinical or radiographic progression-free survival and (c) overall survival. PSA: prostate-specific antigen.